COMP360 psilocybin
COMP202
Phase 3 small_molecule active
Quick answer
COMP360 psilocybin for PTSD - Post Traumatic Stress Disorder is a Phase 3 program (small_molecule) at Compass Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Compass Therapeutics
- Indication
- PTSD - Post Traumatic Stress Disorder
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active